These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21154159)

  • 1. New druggable targets in the Ras pathway?
    Matallanas D; Crespo P
    Curr Opin Mol Ther; 2010 Dec; 12(6):674-83. PubMed ID: 21154159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting RAS signalling pathways in cancer therapy.
    Downward J
    Nat Rev Cancer; 2003 Jan; 3(1):11-22. PubMed ID: 12509763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for personalized medicine with inhibitors targeting the RAS and PI3K pathways.
    Lackner MR
    Expert Rev Mol Diagn; 2010 Jan; 10(1):75-87. PubMed ID: 20014924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAS: target for cancer therapy.
    Saxena N; Lahiri SS; Hambarde S; Tripathi RP
    Cancer Invest; 2008 Nov; 26(9):948-55. PubMed ID: 18798058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailoring Ras-pathway--inhibitor combinations for cancer therapy.
    Blum R; Kloog Y
    Drug Resist Updat; 2005 Dec; 8(6):369-80. PubMed ID: 16356760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer targets in the Ras pathway.
    Rodriguez-Viciana P; Tetsu O; Oda K; Okada J; Rauen K; McCormick F
    Cold Spring Harb Symp Quant Biol; 2005; 70():461-7. PubMed ID: 16869784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in the study of antitumor drug targeting on the Ras signaling pathway].
    Zhu YJ; Jiang FC
    Yao Xue Xue Bao; 2009 Jan; 44(1):1-10. PubMed ID: 19350814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting new anticancer drugs within signalling pathways regulated by the Ras GTPase superfamily (Review).
    Ramírez De Molina A; Rodríguez-González A; Lacal JC
    Int J Oncol; 2001 Jul; 19(1):5-17. PubMed ID: 11408916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to Ras signaling modulation and treatment of Ras-dependent disorders: a patent review (2007--present).
    Sacco E; Spinelli M; Vanoni M
    Expert Opin Ther Pat; 2012 Nov; 22(11):1263-87. PubMed ID: 23009088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raf: a strategic target for therapeutic development against cancer.
    Beeram M; Patnaik A; Rowinsky EK
    J Clin Oncol; 2005 Sep; 23(27):6771-90. PubMed ID: 16170185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
    Fan S; Meng Q; Laterra JJ; Rosen EM
    Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras.
    Erman M
    J BUON; 2007 Sep; 12 Suppl 1():S83-94. PubMed ID: 17935283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation and new molecular agents, part II: targeting HDAC, HSP90, IGF-1R, PI3K, and Ras.
    Chinnaiyan P; Allen GW; Harari PM
    Semin Radiat Oncol; 2006 Jan; 16(1):59-64. PubMed ID: 16378908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: a potential treatment for cancer.
    Rotblat B; Ehrlich M; Haklai R; Kloog Y
    Methods Enzymol; 2008; 439():467-89. PubMed ID: 18374183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ras-ERK pathway: understanding site-specific signaling provides hope of new anti-tumor therapies.
    Calvo F; Agudo-Ibáñez L; Crespo P
    Bioessays; 2010 May; 32(5):412-21. PubMed ID: 20414899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of c-Raf-1: therapeutic implications.
    Beeram M; Patnaik A; Rowinsky EK
    Clin Adv Hematol Oncol; 2003 Aug; 1(8):476-81. PubMed ID: 16258435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges of developing therapeutics that target signal transduction in patients with gynecologic and other malignancies.
    Rowinsky EK
    J Clin Oncol; 2003 May; 21(10 Suppl):175s-186s. PubMed ID: 12743132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key cancer cell signal transduction pathways as therapeutic targets.
    Bianco R; Melisi D; Ciardiello F; Tortora G
    Eur J Cancer; 2006 Feb; 42(3):290-4. PubMed ID: 16376541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In search of novel molecular targets in cancer: the diacyglycerol pathways.
    Lorenzo PS
    Hawaii Med J; 2004 Oct; 63(10):318-9, 321. PubMed ID: 15570721
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
    Roberts PJ; Der CJ
    Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.